Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan

    NEXT STORY
    Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market
    PREV STORY
    Inventiva’s 2020 Full-Year Financial Results Presentation
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Rafael Pharmaceuticals Announces Expansion into Austria, South Korea and Spain of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

    author_avatar
    NASDAQ Market News

    New Study From Trusted Health Finds Significant Decline in Nurses’ Mental Health and Well-being in the Wake of COVID-19, Yet Commitment to the Profession Remains High

    author_avatar
    NASDAQ Market News

    The Asia Pacific E. coli testing market is expected to reach US$ 496.7 million by 2027 from US$ 283.2 million in 2019

    author_avatar
    NASDAQ Market News